NEWS DESK

NSRX Stock News, News Score & What It Could Mean

Nasus Pharma Ltd. Ordinary Shares (NSRX) is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
53/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
50
Structured data unavailable
Confidence
Low
Headline depth
Last Price
DATA UNAVAILABLE
Trend Context
Mixed / range
Latest briefing

What's happening with NSRX

Stock Titan22 Jun 2026

Nasus Pharma (NSRX) CEO adds 6,550 shares in open-market purchase - Stock Titan

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPa19pTzdPR19pOWE1dzZRR0xjRExkT2UxeG9kSThzOXJPbWNoZGhzQTI1NmhodnRQSG10MWdSaFNQRnB3SVBpSGZiazBocmlBYU85enR2VXJyN1pKRWhpekhwcTQ5blNaWkdnTGdWd0JKZHRsV0dHakk5MkRaR1ByRGVfOU1leWtlckF1Q3VtM0lfNEdPekpHYTRpcG1qTTdQS1BQQ1laUDNIZ1JKcEs4?oc=5" target="_blank">Nasus Pharma (NSRX) CEO adds 6,550 shares in open-market purchase</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Investing.com25 Mar 2026

Nasus Pharma reports Phase 2 results for intranasal epinephrine - Investing.com

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQVlVRNjJDaHM0Q3VEbkZvbWhJN1VjLU54M2w3bEczajhSeXRsWGx2V2ZuSmNRVENxUTEweEZnaEkxUk1oMUpBaXNMazhsbUY3NktuUHl2VThaTTlhVnNyTWNOaXJUaHEtdi1UeUtMS3NuYXFIN3RqekF0ZnRNRG0tSXJGbGhGNU0yaGxBMnlTWjVwWHVlMHFZSm00YUVBZGUyRzR2NGRPUzN0akFwQ2I0MlBuYW1pTVl6aUhfdg?oc=5" target="_blank">Nasus Pharma reports Phase 2 results for intranasal epinephrine</a>&nbsp;&nbsp;<font color="#6f6f6f">Investing.com</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Investing.com16 Mar 2026

Nasus Pharma reports faster epinephrine delivery in Phase 2 study - Investing.com

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPZ0NpLTlvSTdqRzFEeUdHNHlKSC1zYmtCcWc4UkFzVEZDaHVMOXFPc2xKOUhjQXNkN3NYNURicHFmQWxVT21ibGV6R0pZS3ZfSzNTTklGWGJmemVDVTJBYlJpZzg1eWtVbFhfSEdDU05fVGFKaWltcF84ZUE2bHBUUHBSdXcxNC1sczFSOENHek1mRml3RlZxd2NrZTk2dkc5NXEyaEVDVzE3MER6ZlpURlZSZGdrc1Y4LWtqdHpPUQ?oc=5" target="_blank">Nasus Pharma reports faster epinephrine delivery in Phase 2 study</a>&nbsp;&nbsp;<font color="#6f6f6f">Investing.com</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
GlobeNewswire
13 Feb 2026
Nasus Pharma Announces Closing of $15.0 Million Private Placement - GlobeNewswire
Read ↗
Stock Titan
13 Aug 2025
Nasus Pharma (NSRX) Stock News & Updates - Stock Titan
Read ↗
Earnings news

NSRX earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
Stock Titan22 Jun 2026

Nasus Pharma (NSRX) CEO adds 6,550 shares in open-market purchase - Stock Titan

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPa19pTzdPR19pOWE1dzZRR0xjRExkT2UxeG9kSThzOXJPbWNoZGhzQTI1NmhodnRQSG10MWdSaFNQRnB3SVBpSGZiazBocmlBYU85enR2VXJyN1pKRWhpekhwcTQ5blNaWkdnTGdWd0JKZHRsV0dHakk5MkRaR1ByRGVfOU1leWtlckF1Q3VtM0lfNEdPekpHYTRpcG1qTTdQS1BQQ1laUDNIZ1JKcEs4?oc=5" target="_blank">Nasus Pharma (NSRX) CEO adds 6,550 shares in open-market purchase</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

2
Kavout | AI23 Apr 2026

What Does the CEO's Recent Purchase Signal for NSRX - Kavout | AI

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQUG81YkxhSnVoOFY5UXJ5Z1VwWklUZF9pZkVYOUV6Q0M1Z04yZzlGNVhRdmp2S2tTRFUydVhrVWJfYklDWGlDM1hLaUo0MlB2QjREY0hYOFIzbDVYemMtOXJNWEhvVVJlLUxiVGVaSkFwSVQ4UEN1Y2F1UFVNajBpZGxhM1d6LTNzNlRxYWZZVQ?oc=5" target="_blank">What Does the CEO's Recent Purchase Signal for NSRX</a>&nbsp;&nbsp;<font color="#6f6f6f">Kavout | AI</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your NSRX research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.